More than one million people in the United States today are fighting blood cancer. While a traditional
allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks.
With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives.
The Orca-T Account Manager (OTAM), Midwest (Associate Director) will serve as the primary liaison between Orca Bio and our Authorized Treatment Centers (ATCs). This individual is responsible for building and managing key relationships, supporting clinical site readiness and execution, and driving appropriate use of Orca Bio’s investigational therapies. The OTAM plays a central role in creating a smooth and effective experience for clinical sites, physicians, and other healthcare stakeholders. This is a high-impact, field-based role that requires both strategic thinking and tactical execution. It offers the opportunity to help shape how groundbreaking therapies are delivered to patients who need them most.
Candidate must be located within territory (Midwest US).
